Simulations Plus, Inc.
NASDAQ:SLPMedical - Healthcare Information Services
+$0.02 today
- Market cap
- $374.16M
- Beta
- 1.32
- P/E (TTM)
- -5.9
- EPS (TTM)
- -$3.12
Volume 0.00M
Average 0.35M
SLP Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Simulations Plus, Inc.NASDAQ: SLP
Cash & Equivalents · Q2 FY2026 · quarter ended Feb 2026
Cash & equivalents rises 134.1% from a year ago
Cash & equivalents stood at $25.73M at the end of Q2 FY2026, up 134.1% from a year earlier and down 14.8% from the prior quarter. Over 3 fiscal years it compounded at -15.7% a year.
Context
- Cash & equivalents amounted to 17.6% of total assets at the end of Q2 FY2026, up 12.1 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +134.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 30.85M USD
- Year-over-year change
- +199.2%
- 4-year CAGR
- -4.4%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-08-31 | 30.85M | +199.2% |
| FY2024 | 2024-08-31 | 10.31M | -82.1% |
| FY2023 | 2023-08-31 | 57.52M | +11.6% |
| FY2022 | 2022-08-31 | 51.57M | +39.4% |
| FY2021 | 2021-08-31 | 36.98M | — |
Cash & Equivalents vs competitors
How SLP compares with its peers on the latest reported figures
- Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +134.1% is the 2nd highest of 11, against a peer median of +1.4%.
- Cash & equivalents amounts to 17.6% of total assets for SLP, versus a peer median of 13.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $263.76M USD | +64.1% | +54.0% | 95.5% | |
| Mar 2026 | $157.65M USD | +48.6% | +3.7% | 30.6% | |
| Mar 2026 | $139.99M USD | +1.0% | -28.0% | 9.3% | |
| Mar 2026 | $65.39M USD | -4.6% | -24.2% | 41.7% | |
| Mar 2026 | $61.7M USD | -3.8% | -16.1% | 33.6% | |
| Mar 2026 | $35.3M USD | +2994.9% | +394.4% | 5.7% | |
| Mar 2026 | $35M USD | -72.6% | -10.9% | 12.1% | |
| Feb 2026 | $25.73M USD | +134.1% | -15.7% | 17.6% | |
| Mar 2026 | $20.17M USD | +21.7% | +8.7% | 12.1% | |
| Mar 2026 | CHF 19.17M CHF | -4.0% | -5.3% | 13.9% | |
| Mar 2026 | $2.55M USD | +1.8% | -45.1% | 1.9% | |
| Peer median (excluding SLP) | — | +1.4% | -8.1% | 13.0% | |
Competitors are the stored peer set for SLP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Aug 2021 | FY2022 Aug 2022 | FY2023 Aug 2023 | FY2024 Aug 2024 | FY2025 Aug 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 36.98M | 51.57M | 57.52M | 10.31M | 30.85M |
| Short-term Investments | 86.62M | 76.67M | 57.94M | 9.94M | 1.5M |
| Net Receivables | 13.05M | 13.79M | 10.2M | 9.14M | 14.62M |
| Inventory | 1.01M | 1.39M | 804K | 0 | 0 |
| Other Current Assets | 1.65M | 3.38M | 3.9M | 7.75M | 2.8M |
| Total Current Assets | 139.31M | 146.79M | 130.37M | 39.34M | 51.55M |
| Property, Plant & Equipment (Net) | 3.11M | 2.05M | 1.92M | 1.84M | 1.29M |
| Goodwill | 12.92M | 12.92M | 19.1M | 96.08M | 43.72M |
| Intangible Assets | 24.58M | 26.18M | 32.85M | 58.84M | 29.21M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 1.64M | 2.12M | 7.98M | 11M | 4.77M |
| Other Non-current Assets | 51K | 439K | 425K | 542K | 1.4M |
| Total Non-current Assets | 42.3M | 43.71M | 62.27M | 168.3M | 80.39M |
| Total Assets | 181.61M | 190.5M | 192.64M | 207.64M | 131.94M |
| Account Payables | 387K | 225K | 144K | 602K | 470K |
| Short-term Debt | 382K | 461K | 442K | 475K | 206K |
| Tax Payables | 1.01M | 1.39M | 804K | 2.2M | 1.78M |
| Deferred Revenue | 651K | 2.86M | 3.1M | 2M | 2.7M |
| Other Current Liabilities | 10.15M | 931K | 3.91M | 4.48M | 1.34M |
| Total Current Liabilities | 11.57M | 7.74M | 11.99M | 12.07M | 6.73M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 3.36M | 3.58M | 6.54M | 12.61M | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 3.33M | 0 | 0 |
| Total Non-current Liabilities | 4.26M | 4.52M | 10.62M | 13.14M | 410K |
| Total Liabilities | 15.83M | 12.26M | 22.61M | 25.21M | 7.14M |
| Common Stock | 133.42M | 138.51M | 144.97M | 20K | 20K |
| Retained Earnings | 32.41M | 40.04M | 25.2M | 30.35M | (34.36M) |
| Accumulated OCI | (43K) | (308K) | (141K) | (251K) | (271K) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 165.78M | 178.25M | 170.03M | 182.43M | 124.8M |
| Total Debt | 1.28M | 1.4M | 1.2M | 1.01M | 616K |
| Net Debt | (35.71M) | (50.16M) | (56.33M) | (9.31M) | (30.24M) |
Simulations Plus, Inc.
NASDAQ:SLP
Intrinsic Alpha fair value
Locked
Current Price
$18.50
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.